Papillary Thyroid Microcarcinoma clinical trials
The registry lists 24 studies for Papillary Thyroid Microcarcinoma across 8 countries. 8 are recruiting or about to start. 21 of them are mainly about Papillary Thyroid Microcarcinoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04.
Get an email when these change. Save the Papillary Thyroid Microcarcinoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Phase
- Phase 2
- 1
Who runs them
Memorial Sloan Kettering Cancer Center (3) · Seoul National University Hospital (2) · University Health Network, Toronto (1) · The University of Hong Kong (1) · Chinese PLA General Hospital (1) · Cedars-Sinai Medical Center (1) · University of Maryland, Baltimore (1) · Mayo Clinic (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Dec 2026Efficacy and Prognosis of Microwave Ablation Treatment for Papillary Thyroid Microcarcinoma Assessed by Contrast-Enhanced Ultrasound Combined With Genetic and Molecular Diagnostics: A Prospective Observational Study · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Nov 2027RFA Treatment for Papillary Thyroid Microcarcinoma · Columbia University
Who these studies take
Of the 6 Papillary Thyroid Microcarcinoma studies recruiting now, 5 (83%) set no upper age limit and 1 (17%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 6 (100%) | 6 (100%) |
| 30 | 6 (100%) | 6 (100%) |
| 40 | 6 (100%) | 6 (100%) |
| 50 | 6 (100%) | 6 (100%) |
| 65 | 6 (100%) | 6 (100%) |
| 75 | 5 (83%) | 5 (83%) |
| 85 | 5 (83%) | 5 (83%) |
Across all 24 studies, recruiting or not: 17% stop at 75 or younger and 8% at 65; 17% take children; 0% are for women only and 0% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 24 of 24. search them.
- Active Surveillance of Papillary Thyroid MicrocarcinomaRecruitingNCT02609685Not applicable1 country
- RFA Treatment for Papillary Thyroid MicrocarcinomaRecruitingNCT051898211 country
- Decision Aid Efficacy in Low Risk Thyroid CancerNot yet recruitingNCT07536412Not applicable1 country
- Genomic Predictors of Papillary Microcarcinoma Disease ProgressionRecruitingNCT023635951 country
- Safety and Quality of Life of Three Treatment Strategies for Low-Risk Papillary Thyroid MicrocarcinomaNot yet recruitingNCT072491251 country
- Efficacy and Prognosis of Microwave Ablation Treatment for Papillary Thyroid Microcarcinoma Assessed by Contrast-Enhanced Ultrasound Combined With Genetic and Molecular Diagnostics: A Prospective Observational StudyRecruitingNCT070542291 country
- Minimally Invasive Treatments of the ThyroidRecruitingNCT063335871 country
- Active Surveillance Versus Surgery in Thyroid Papillary MicrocarcinomaRecruitingNCT04129281Not applicable1 country
- Laser Ablation of Papillary Thyroid MicrocarcinomaActive, not recruitingNCT04623801Phase 21 country
- Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid CarcinomasCompletedNCT075061611 country
- Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid CancerActive, not recruitingNCT046244771 country
- 10 Years' Follow-up Results of Ultrasound-guided Radiofrequency Ablation Versus Surgery for Low-risk Papillary Thyroid Micro-carcinomaCompletedNCT07107503
- Treatment of Papillary Thyroid Carcinoma With Radiofrequency AblationCompletedNCT04129411Not applicable1 country
- PMRA and Shapley-Based Machine Learning for Predicting Lymph Node Metastasis in Central Subregions of Clinically Node-Negative Papillary Thyroid Microcarcinoma: a Prospective Multicenter Validation and Development of a Web CalculatorCompletedNCT068719561 country
- Multicenter Comparison of Thermal Ablation Versus Thyroid Lobectomy for Subcapsular Papillary Thyroid MicrocarcinomaCompletedNCT065830571 country
- Radiofrequency Ablation of Low Risk Papillary Thyroid MicrocarcinomaStatus unknownNCT03432299Not applicable1 country
- A Trial Comparing USG-HIFU vs AS in Management of Low-risk PTMCSuspendedNCT03327636Not applicable1 country
- Active Surveillance on Papillary Thyroid MicrocarcinomaActive, not recruitingNCT029387021 country
- A Multicenter Trial of PLA vs. Surgery for Treating PTMCStatus unknownNCT03377829Not applicable2 countries
- A Multicenter Trial of Radiofrequency Ablation vs. Surgery as Treatment of Papillary Thyroid Microcarcinoma.Status unknownNCT03808779Not applicable2 countries
- Microbiome and Papillary Thyroid MicrocarcinomaStatus unknownNCT04376203
- Genetic Expression Alteration Affect on Lateral Neck Node Metastasis of Thyroid Papillary Microcarcinoma : Microarray AnalysisCompletedNCT013846691 country
- Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant OthersCompletedNCT013922221 country
- Long-term Outcomes of Total Thyroidectomy Versus Less Than Total Thyroidectomy for Papillary Thyroid MicrocarcinomaCompletedNCT016485691 country